Huntsman Cancer Institute (HCI) is part of the University of Utah Health Care system. HCI is a National Cancer Institute (NCI)-Designated Comprehensive Cancer Center, which means it meets the highest standards for cancer care and research and receives support for its scientific endeavors. Learn more about our Cancer Center Research Programs. HCI is also a member of the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of the world’s leading cancer centers. NCCN is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Hope Through Research: HCI scientists focus on understanding cancer from its beginnings to create safer and more effective treatments. Researchers also investigate how genes function to discover possible methods of preventing, circumventing, or even reversing the genetic changes that cause cancer.
Hope Through Education: HCI offers free information about cancers, risk factors, screening, prevention, and treatments to patients, family members, physicians, and the public.
Hope Through Care: At HCI, teams of doctors and health care professionals work together to provide compassionate, state-of-the-art care.
Our Patient Reach
HCI serves thousands of cancer patients throughout the Intermountain West every year and provides academic and clinical training for future physicians and researchers. Most of our patients come from Utah, a state that covers more than 80,000 square miles, of which 96% is rural (<100 people/square mile) and 70% is frontier (<7 people/square mile). Utah is also home to seven Native American tribes or nations.
Although Utah is our primary catchment area, patients are referred from a broad, multistate region that includes portions of Idaho, Montana, Nevada, and Wyoming—an area rich in special populations that are historically underserved and exhibit poor cancer outcomes compared to the U.S. average.
HCI is committed to equity in research opportunities for all genders and minority groups in our catchment area. We ensure every person receives excellent cancer care and is able to benefit from the latest advances in cancer diagnosis, treatment, and prevention strategies through participation in clinical trials.